These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12404825)

  • 1. Oral contraceptives.
    Weisberg E
    Aust Fam Physician; 2002 Oct; 31(10):891-6. PubMed ID: 12404825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contraceptive dilemmas.
    Guthrie K; Searle S
    Practitioner; 1994 Aug; 238(1541):567-9, 571-4. PubMed ID: 8072939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing oral contraceptives and the medical record.
    Benn M
    Aust Fam Physician; 1991 Oct; 20(10):1469-71. PubMed ID: 1793398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptives, hormone therapy and cardiovascular risk.
    Shapiro S
    Climacteric; 2008 Oct; 11(5):355-63. PubMed ID: 18781479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined hormonal contraception and venous thromboembolism.
    Martínez F; Avecilla A
    Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):97-106. PubMed ID: 17559006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of contraceptives on the skin.
    Aust Fam Physician; 1988 Oct; 17(10):853, 856. PubMed ID: 3240155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of venous thromboembolism in young Swedish women and possibly preventable cases among combined oral contraceptive users.
    Samuelsson E; Hägg S
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):674-81. PubMed ID: 15225194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combined oral contraceptive pill. A practical review of current options.
    Riddoch G
    Aust Fam Physician; 2000 Nov; 29(11):1039-44. PubMed ID: 11127060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yasmin: the reason why.
    Thorneycroft IH
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():13-8; discussion 42-3. PubMed ID: 12659402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.
    Tanis BC; Rosendaal FR
    Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptive therapy in women: drug interactions and unwanted outcomes.
    Schwartz JB
    J Gend Specif Med; 1999; 2(6):26-9. PubMed ID: 11279868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens.
    van Vliet HA; Frolich M; Christella M; Thomassen LG; Doggen CJ; Rosendaal FR; Rosing J; Helmerhorst FM
    Hum Reprod; 2005 Feb; 20(2):563-8. PubMed ID: 15539435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptives and the absolute risk of venous thromboembolism in women with single or multiple thrombophilic defects: results from a retrospective family cohort study.
    van Vlijmen EF; Brouwer JL; Veeger NJ; Eskes TK; de Graeff PA; van der Meer J
    Arch Intern Med; 2007 Feb; 167(3):282-9. PubMed ID: 17296885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty or thirty microgram ethinyloestradiol in an oral contraceptive: does it make a difference in the mind and the daily practise of gynaecologists and general practitioners?
    Bitzer J; Frey B; von Schönau M; Sabler N; Tschudin S
    Eur J Contracept Reprod Health Care; 2009 Aug; 14(4):258-67. PubMed ID: 19513939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms.
    Apter D; Borsos A; Baumgärtner W; Melis GB; Vexiau-Robert D; Colligs-Hakert A; Palmer M; Kelly S
    Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):37-51. PubMed ID: 12725674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tasmanian survey of pill symptoms.
    Riddoch GG; Duncombe P; Kovacs G
    Aust Fam Physician; 1996 Jan; Suppl 1():S38-40. PubMed ID: 9479798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraception in women with epilepsy: pharmacokinetic interactions, contraceptive options, and management.
    Dutton C; Foldvary-Schaefer N
    Int Rev Neurobiol; 2008; 83():113-34. PubMed ID: 18929078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helping women choose appropriate hormonal contraception: update on risks, benefits, and indications.
    Spencer AL; Bonnema R; McNamara MC
    Am J Med; 2009 Jun; 122(6):497-506. PubMed ID: 19486709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.